The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.
Open accessAbstract
An interleukin 4 (IL-4)-specific monoclonal antibody (mAb) was administered to mice infected systemically with the yeast Candida albicans, and the animals were monitored for mortality, development of delayed-type hypersensitivity, production of antibodies of different isotypes, release of IL-2, IL-4, IL-6, and interferon gamma (IFN-gamma) in vitro by splenic CD4+ lymphocytes, and levels of IL-4 and IFN-gamma mRNA in these cells. Neutralization of IL-4 by three weekly injections of mAb in several independent experiments resulted in an overall cure rate of 81% versus 0% of controls. Cure was associated with efficient clearance of the yeast from infected organs and histologic evidence of disease resolution, detection of strong T helper type 1 (Th1) responses, and establishment of long-lasting protective immunity. Soon after infection, and as a result of the first or second injection of mAb, there was a decrease in IL-4 mRNA in CD4+ cells, which was accompanied by an increase in the levels of IFN-gamma-specific transcripts. Our data thus indicate that the production of IL-4 by Th2 cells may limit Th1-associated protective immunity in murine candidiasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Cited by
Seder, R. A., Gazzinelli, R., Sher, A., & Paul, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10188 · Cited by 976
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice
Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., & Lattanzio, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07185.x · Cited by 407
Self-citationRole of cytokines in determining T-lymphocyte function
O'Garra, A., & Murphy, K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90128-7 · Cited by 393
Brunner, T., Heusser, C. H., & Dahinden, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.605 · Cited by 380
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Cytokine production at the site of disease in human tuberculosis
Barnes, P. F., Lu, S., Abrams, J. S., Wang, E., Yamamura, M., & Modlin, R. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3482-3489.1993 · Cited by 371
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., & Poli, V (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1345 · Cited by 313
Self-citationTh1-Th2: Reliable paradigm or dangerous dogma?
Allen, J. E., & Maizels, R. M. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01102-x · Cited by 306
Ning, Q., Brown, D., Parodo, J., Cattral, M., Gorczynski, R., Cole, E., Fung, L., Ding, J. W., Liu, M. F., Rotstein, O., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3487 · Cited by 303
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
Röcken, M., Racke, M., & Shevach, E. M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80556-1 · Cited by 264
Avraham, T., Zampell, J. C., Yan, A., Elhadad, S., Weitman, E. S., Rockson, S. G., Bromberg, J., & Mehrara, B. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-222695 · Cited by 241
Iron Overload Alters Innate and T Helper Cell Responses to Candida albicans in Mice
Mencacci, A., Cenci, E., Boelaert, J. R., Bucci, P., Mosci, P., d'Ostiani, C. F., Bistoni, F., & Romani, L. (1997) · The Journal of Infectious Diseases · doi:10.1086/516481 · Cited by 169
Self-citationInnate and adaptive immunity in Candida albicans infections and saprophytism
Romani, L. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.2.175 · Cited by 106
Self-citationIbrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83
“, indicating that cell-mediated (type 1), rather than humoral (type 2), immunity is the key to host protection against murine disseminated candidiasis (6, 49, 57, 59).”
BackgroundBromuro, C., La Valle, R., Sandini, S., Urbani, F., Ausiello, C. M., Morelli, L., Féd’ostiani, C., Romani, L., & Cassone, A. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2154-2162.1998 · Cited by 73
IFN-γ Is Required for IL-12 Responsiveness in Mice with Candida albicans Infection
Cenci, E., Mencacci, A., Del Sero, G., Fé d’Ostiani, C., Mosci, P., Bacci, A., Montagnoli, C., Kopf, M., & Romani, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3543 · Cited by 67
Self-citationChoi, E. H., Foster, C. B., Taylor, J. G., Erichsen, H. C., Chen, R. A., Walsh, T. J., Anttila, V., Ruutu, T., Palotie, A., & Chanock, S. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/368345 · Cited by 52
Metadata
- Authors
- Romani, L., Mencacci, A., Grohmann, U., Mocci, S., Mosci, P., Puccetti, P., & Bistoni, F.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-07-01
- Volume
- 176
- Issue
- 1
- Pages
- 19-25
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169772540
- Cited by
- 195
- References
- 1
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.